INTRODUCTION
============

Parasitic species belonging to the kinetoplastid group of protozoans are of high medical and veterinary importance mainly in tropical and subtropical countries. These include trypansomatids such as *Leishmania* spp. (Leishmaniasis), *Trypanosoma brucei* (Sleeping sickness) and *Trypanosoma cruzi* (Chagas disease). Their life cycle involves a mammalian host and an arthropod vector. The parasites face disparate conditions during their life cycle, a drastic change in temperature between their insect (∼20--25°C) and mammalian (37°C) hosts being typically a shared challenge. Other changes can be unique to the life style of a given parasite (e.g. the acidic pH that *Leishmania* spp. face within the phagolysosomes of host macrophages). The parasites employ various adaptive strategies to be able to survive and grow in their distinct niches. These stage- or species-specific structural and metabolic adaptations are associated with significant changes in gene expression as evidenced by recent functional genomic analyses \[Rochette *et al.*, unpublished data; ([@B1; @B2; @B3; @B4])\].

Kinetoplastids branched very early from the eukaryotic lineage and perhaps because of these they display several unusual or unique biological features. Tens to hundreds of genes are collinearly transcribed into a polycistronic mRNAs ([@B5; @B6; @B7]). Individual mRNAs are resolved from nuclear pre-mRNAs via coupled co-transcriptional processes of *trans*-splicing and 3′-end cleavage/polyadenylation ([@B8]). The process of *trans*-splicing involves the addition of ∼40-bases long capped mini-exon to the 5′-termini of all mRNAs from a separate RNA substrate (*SL-RNA*) \[reviewed in ([@B8])\]. Transcription has been postulated to initiate at strand switch regions on each chromosome probably within the intercistronic regions ([@B9],[@B10]). There is, however, no indication for specific RNA polymerase II promoters associated with protein-coding genes to-date and the genomes of the parasites are short of genes encoding major transcription factors and co-activators. Consequently, most of gene regulation in these parasites occurs at the post-transcriptional levels, mainly via mRNA stability and translation \[reviewed in ([@B11],[@B12])\].

Eukaryotic mRNAs are typically capped at their 5′-ends and possess poly(A) tail at their 3′-ends. Such modifications at the mRNA termini, plus the proteins they bind to, confer mRNA stability and translatability. The degradation of eukaryotic mRNA is typically triggered by poly(A) tail shortening \[reviewed in ([@B13])\]. Deadenylation, in turn, invokes decapping and the cumulative outcome is unprotected ends that are readily attacked by 5′- and 3′-exonucleases \[reviewed in ([@B13],[@B14])\]. Two 5′-exonucleases have been identified in yeast, the nuclear Rat1p/Xrn2p and the cytoplasmic Xrn1p ([@B15],[@B16]). More than 10 conserved 3′-exonucleases have been characterized and some, together with other protein factors, are found in a complex called the exosome. Besides their role in determining mRNA half-lives in the cytoplasm, the 3′- and 5′-exonucleases are also involved in pre-mRNA quality control and the maturation of ribosomal, nuclear and small nucleolar RNAs \[for examples see ([@B17; @B18; @B19])\]. In yeast, degradation from the 5′-end seems to be the major determinant of mRNA degradation and the 3′-pathway is only detectable in mutants of the 5′-pathway \[reviewed in ([@B13])\]. In mammals, there is a growing consensus that both pathways are probably significant determinants of mRNA degradation ([@B20; @B21; @B22]).

The genomes of trypanosomes harbor genes that encode for deadenylases \[reviewed in ([@B11])\]. A clear orthologue of a decapping enzyme has so far proven to be elusive even though decapping activity has been detected in the related organism *Leptomonas seymouri* ([@B23]). Degradation of mRNAs in *T. brucei* involves both 5′- and 3′-pathways ([@B24]) and homologues of all major 3′-exonucleases ([@B25; @B26; @B27]), and 5′-exonucleases ([@B28]) are well-characterized. Trypanosome 3′-exonucleases are also found in a complex and display all major RNA processing and degradation functions associated with their counterparts in other eukaryotes ([@B25],[@B26],[@B29],[@B30]). Trypanosomes harbor four homologues of Xrn1p and Xrn2p/Rat1p ([@B28]). One of these, termed XRNA, is cytoplasmic and has been shown to be critical in the degradation of both stable and unstable mRNAs in *T. brucei* ([@B28]).

mRNA degradation *cis* determinants are predominantly found in the 3′-untranslated regions (UTRs) in all three species of trypanomatids. In *Leishmania*, in contrast to other trypansomatids, several hundred of the 3′UTR *cis*-elements belong to two major classes of short interspersed degenerate retroposons, SIDER1 and SIDER2 ([@B31]), and several lines of evidence indicate that these elements modulate post-transcriptional gene expression in this parasite ([@B31; @B32; @B33]). These elements are thought to have evolved specifically in the *Leishmania* lineage perhaps under the selective pressure presented by the parasite′s unique niches. Whether or not the mechanisms through which these elements function are also unique remains to be determined. The degradation of several unstable mRNAs in *T. brucei* \[reviewed in ([@B11]) and *T. cruzi* ([@B34])\] is dependent on U-rich elements (UREs). These elements seem to be structurally ([@B35]) and functionally ([@B24],[@B29],[@B36; @B37; @B38; @B39; @B40]) similar to the mammalian AU-rich elements (AREs) found in several proto-oncogene and inflammatory cytokine mRNAs ([@B41]). These elements confer instability in a number of mRNAs in procyclic trypanosomes, developmental forms of the parasite that reside in the mid-gut of the insect vector. In *T. cruzi*, protein factors (UBPs) that bind these elements with high affinity and avidity have been identified ([@B34],[@B42],[@B43]). Homologues of these RNA-binding proteins also exist in *T. brucei* even though these proteins seem to have broad RNA-binding specificity ([@B44]). No UREs have been reported in *Leishmania* so far and virtually nothing is known about mechanisms underlying mRNA degradation in these parasites. In this study, we demonstrate URE-mediated degradation of the stage-specific amastin mRNA in *Leishmania*, thereby embark on attempts to gain insight into the mechanistic basis of mRNA degradation in this organism.

MATERIALS AND METHODS
=====================

Plasmids
--------

The parental plasmid used in this study, pSPBT1-YNEOαLUC, was previously described ([@B33]). This plasmid allows the integration of reporter constructs into the *BT1* genomic locus. Sequence corresponding to the amastin (LinJ34_V3.1030) 3′UTR and downstream intergenic region was amplified by PCR from *L. infantum* LEM 1317 genomic DNA (gDNA) using the forward primer, amastin-3′UTR-F (5′-AAGCTACTTC[GGATCC]{.ul}GCGG-3′) and the reverse primer, amastin-IR-R (5′-[GGATCC]{.ul}GGCTCGCCAGTGTAGCAGAA-3′). The URE deletion construct was made by fusion PCR as described ([@B45]). Primers amastin-3′UTR-F and amastin-Up-URE-R (5′-CGTCCATGCGGCTCTTCTCTGCGCGTGCGTGTGTGTCG-3′) were used to amplify the upstream region from the URE. Primers amastin-Down-URE-F (5′-CGACACACACGCACGCGCAGAGAAGAGCCGCATGGACG-3′) and amastin-IR-R, was used to amplify the downstream region of the URE. Primer amastin-Up-URE-R is the reverse complement of primer amastin-Down-URE-F. One hundred nanograms of the resulting PCR products, together with primers Amastin-3′UTR-F and amastin-IR-R, were used for a fusion PCR to generate amastin 3′UTR▵URE. The only difference between full-length 3′UTR and 3′UTR-ΔURE is, therefore, the deletion of the 100-nt long URE. The resulting PCR fragments were digested with *Bam*HI (primers amastin-3′UTR-F and amastin-IR-R contain this site) and cloned into the *Bam*HI site of the pSPBT1-YNEOαLUC plasmid, downstream of the firefly luciferase (*LUC*) open reading frame ([Figure 2](#F2){ref-type="fig"}).

Parasite culture and transfections
----------------------------------

*Leishmania donovani infantum* MHOM/MA/67/ITMAP-263, the parental strain for all the parasite lines employed in this study, was cultured in SDM-79 medium (pH 7), supplemented with 10% heat-inactivated fetal calf serum (Multicell, Wisent Inc.) and 5 mg/ml hemin at 25°C as promastigotes and were switched to MAA/20 medium (pH 5.8) at 37°C with 5% CO~2~ and passed ∼2--3 times to generate axenic amastigotes ([@B46]). For genomic integration into the *BT1* locus, ∼2.5 μg of *Hpa*I-*Hin*dIII digests (these enzymes only cut on either side of the *BT1* targeting regions) were transfected into promastigote *L. infantum* by electroporation as described ([@B47]). Transfected cells were plated on SDM-79 medium with 1.5% agar and 0.01 mg/ml of G418 (Sigma), and individual clones were obtained after 2--3 weeks.

RNA analysis
------------

Parasites were treated with 0.5 µg/ml Actinomycin-D (Sigma) with/without 2.5 µM Sinefungin (Sigma) for mRNA decay rate determination. All time points include 5 min of centrifugation times. Total RNA was extracted from cultures with OD~600nm~ = 0.3--0.5 after lysis with Trizol (Invitrogen) according to the manufacturer\'s instructions. Ten to forty micrograms RNA was used for standard RNA blotting. Hybridization was done at 42°C with 50% formamide solution and RNA gels were transfered into Hybond-N membranes (Amersham Biosciences) by upward capillary movement. RNase-H (Invitrogen) digestions were carried out as described with 20--60 μg RNA as a starting material ([@B48]) in the presence of a specific oligonucleotide 300R (5′-TTGTCTCCGTTCCTCC GGGATCCCG-3′) with or without oligo dT (Invitrogen) and the reaction contained RNase inhibitor (Invitrogen). RNase H samples were run typically on 25 cm × 20 cm, 2--2.4% agarose gels. Polyacrylamide gels were 5% and transfer was carried out using BioRad\'s submarine system. Blots were probed with a fragment corresponding the last 300 bases of the amastin mRNA. Ten to twenty micrograms RNA was used as a starting material for the Terminator (Epicentre Biotechnologies) treatments of RNA samples. The reactions were carried out according to manufacturer\'s instructions at 30°C for 1--1.5 h and an RNase inhibitor (Invitrogen) was included in the reaction. Minus Terminator controls were treated equally except that the enzyme was not added. The reaction was stopped by adding 5 mM EDTA, and was directly analyzed by an RNA blot after denaturation in standard MOPS loading buffer. All quantifications of RNA blots were done using the ImageQuant 5.2 software.

Luciferase assay
----------------

10^7^ parasites were resuspended in 100 μl of lysis buffer (25 mM Tris--phosphate at pH 7.8, 2 mM dithiothreitol, 1% Triton X-100, 10% glycerol) and incubated at room temperature for 30 min, then transferred at −80°C for 2 h or overnight. After thawing, 20 μl of the parasite lysates was added to 96-well plates. One hundred microliters of luciferase assay buffer \[20 mM tricine, 1.07 mM (MgCO~3~)4.Mg(OH)2.5 H~2~O, 2.67 mM MgSO~4~, 0.1 mM EDTA, 270 mM coenzyme A, 470 mM luciferin, 530 mM adenosine triphosphate, 33.3 mM DTT\] was added to each well. Bioluminescence was measured using a Dynex MLX luminometer.

RESULTS
=======

Quantitative analysis of the stage-specific mRNA regulation of the amastin mRNA
-------------------------------------------------------------------------------

This study attempted to begin to elucidate mechanisms underlying mRNA degradation in *Leishmania* using the amastin mRNA as a model. The amastin gene encodes a putative surface antigen and is a member of a multi-gene family ([@B49],[@B50]). What we refer to as amastin in this paper is the original gene that was first identified-LinJ34_v3.1030 ([@B51]). We previously demonstrated that most of the amastin mRNAs accumulate preferentially in amastigotes due to increased mRNA stability ([@B49],[@B51]).

We first wished to obtain a quantitative data on the amastin mRNA regulation by using an additional probe that is specific to the mRNA\'s 3′UTR, the last 300 bases (probe 300) to exclude possible cross-reactivity with other amastins. Overall the amastin mRNA is ∼3.9 more abundant in axenic amastigotes than in promastigotes-the developmental forms of the parasite that reside in the mammalian host and the insect vector, respectively ([Figure 1](#F1){ref-type="fig"}A). The values obtained using the amastin coding sequence as a probe and the probe 300 are comparable and [Figure 1](#F1){ref-type="fig"}A is representative of both. The decay kinetics of mRNAs was followed upon inhibition of *de novo* transcription using Actinomycin D and in some cases together with the arrest of splicing using Sinefungin. Sinefungin is assumed to prevent the splicing of pre-made pre-mRNAs by inhibiting the *de novo* methylation of the cap structure of the Spliced-Leader RNA (*SL-RNA*) and/or mRNA maturation from incomplete transcriptional inhibition. The combination of the two drugs was previously suggested to be important in drawing a more accurate representation of decay rates ([@B11],[@B30]). Based on an analysis using the probe 300, the amastin mRNA decays with an overall half-life of ∼40 min in promastigotes versus \>120 min in amastigotes ([Table 1](#T1){ref-type="table"}, [Figure 1](#F1){ref-type="fig"}B). Figure 1.Endogenous amastin mRNA steady-state levels and decay kinetics. (**A**) RNA blot analysis of the amastin mRNA levels in promastigotes (Pro) and amastigotes (Ama). 18S was used as a loading control. Graphic representation of the data is shown in the right panel and values are relative to promastigotes. Blots were probed with one fragment which is complementary specifically to the last 300 bases of the amastin 3′UTR (probe 300, an average of three experiments), and another probe corresponding to the amastin-coding region (five experiments). (**B**) Decay kinetics of the amastin mRNA in promastigotes and amastigotes. 18S was used as a loading control. Blots were hybridized with probe 300. Note that the promastigote blot is over-exposed and comparison of steady-state levels with the amastigote blot is not advisable in this case. mRNA levels from different time points after transcriptional arrest with actinomycin-D (ACT-D) and inhibition of splicing with Sinefungin (SIN) were expressed relative to time 0 and data are representative of two experiments. '--15' denotes pre-treatment with SIN (including centrifugation time) before ACT-D is added at time 0. Graphic representations of the experiments are shown in the bottom panel. The absolute mRNA half-life values (*t*~1/2~) in promastigotes and amastigotes are indicated. For mRNA half-life values derived from ACT-D treatment alone see Table 1. Table 1.mRNA half-lives for the endogenous amastin and reporter mRNAs analysed in this studymRNAmRNA half-lives (min)ACT-DACT-D + SINProAmaProAmaAmastin45 ± 20\>12045 ± 15\>180LUC-3′UTR31.3 ± 19.682.5 ± 10.628 ± 15.5[^a^](#TF1){ref-type="table-fn"}115 ± 10LUC-3′UTRΔURE\>12076 ± 1.463 ± 21.3[^a^](#TF1){ref-type="table-fn"}137 ± 5[^1][^2]

Stage-specific mRNA accumulation of the amastin mRNA is mediated through its 3′UTR
----------------------------------------------------------------------------------

We asked if the stage-specific accumulation of the amastin mRNA is mediated through sequences in the 3′UTR, as is the case for most trypanosomatid mRNAs studied to date. For this and subsequent analysis, we made a bicistronic Neomycin-Luciferase (NEO-LUC) construct which contained the 3′UTR and the downstream intergenic region of the endogenous amastin locus directly after the LUC-coding sequence ([Figure 2](#F2){ref-type="fig"}A). The construct also included additional intergenic and artificial sequences that allowed the proper maturation of the reporter LUC and the selectable marker NEO mRNAs. The NEO-LUC cassette is flanked by sequences that allowed the targeting of the construct into the Biopterin Transporter 1 (*BT1*) genomic locus by homologous recombination (data not shown). The protein encoded by the *BT1* gene is not required under culture conditions in biopterin-rich media but it is essential otherwise ([@B52]). The *BT1* locus is, therefore, used routinely for the integration of transgenic constructs, particularly when a physiologically relevant expression level is desirable. All the other sequences except the 3′UTR have been used routinely in several published \[e.g. ([@B33])\] and unpublished reporter gene analysis and they do not affect RNA levels between promastigotes and amastigotes. Any difference in the LUC-amastin 3′UTR mRNA (*LUC-3′UTR*) levels should therefore be due to the amastin 3′UTR. [Figure 2](#F2){ref-type="fig"}B shows that *LUC-3′UTR* mRNA is ∼3.2-fold higher in amastigotes than in promastigotes, comparable with the regulation of the endogenous amastin mRNA ([Figure 1](#F1){ref-type="fig"}A). mRNA decay analysis of the *LUC-3′UTR* showed that its half life is ∼30 min in promastigotes and ∼80 min in amastigotes ([Table 1](#T1){ref-type="table"}, [Figure 3](#F3){ref-type="fig"}). In promastigotes, ∼50--60% the *LUC-3′UTR* mRNA population are degraded with a half-life of ∼10--15 min ([Figure 3](#F3){ref-type="fig"}A and B). The rest of the population (40--50%) is degraded with a slower kinetics, the half-life being ∼45 min ([Figure 3](#F3){ref-type="fig"}A and B, data not shown). These results suggest that the stage specificity of the steady-state levels and degradation kinetics of the amastin mRNA are mediated mainly through sequences in its 3′UTR and that degradation is probably bi-phasic. Figure 2.The use of reporter mRNAs to demonstrate the role of specific 3′UTR sequences in the stage-specific accumulation of the amastin mRNA. (**A**) Schematic representation of the reporter constructs, LUC-3′UTR and LUC-3′UTRΔURE. The exact sequence of the U-rich element (URE) that is deleted in LUC-3′UTRΔURE is indicated. The NEO-LUC bicistron is flanked with sequences that allow construct targeting to the endogenous *BT1* locus via homologous recombination. Y is a polypyrimidine stretch that allows 5′-end splicing of the Neomycin phosphotransferase (*NEO*) mRNA. αTub IR stands for the intergenic region of the alpha-tubulin gene and allows the 3′-end maturation of the *NEO* mRNA and the 5′-maturation of the Luciferase (*LUC*) mRNA. Ama IR denotes the intergenic region of the amastin gene, which allows the 3′-end maturation of the *LUC* mRNA. (**B**) RNA blot analysis of *LUC-3′UTR* and *LUC-3′UTRΔURE* mRNA levels in promastigotes (Pro) and amastigotes (Ama). 18S was used as a loading control. Graphic representation of the steady-state reporter mRNA levels is indicated in the right panel. Values are expressed relative to promastigote *LUC-3′UTR* mRNA levels. Data are derived from two to three experiments but 11 experiments for the *LUC-3′UTR* versus *LUC-3′UTRΔURE* comparisons in promastigotes. The *P*-value for the *LUC-3′UTR* versus *LUC-3′UTRΔURE* in promastigotes is shown and was calculated using Excel\'s Type 3 two-tailed *T*-test. (**C**) Luciferase activity in promastigotes. Luciferase (LUC) protein levels were inferred by measuring LUC enzymatic activity. Data are derived from three experiments. Figure 3.Decay kinetics of reporter mRNAs. mRNA decay rate was followed after inhibition of transcription alone with Actinomycin D (ACT-D) for *LUC-3\'UTR* versus *LUC-3′UTRΔURE* in promastigotes (Pro) (**A**), ACT-D plus Sinefungin (SIN) for *LUC-3′UTR* versus *LUC-3′UTRΔURE* in Promastigotes (**B**) and ACT-D alone for *LUC-3′UTR* versus *LUC-3′UTRΔURE* in amastigotes (Ama) (**C**). '--15' time point in (**B**) represents a pre-treatment with SIN (including centrifugation time) before the addition of ACT-D at time 0. Histone 4A (Hist4A) was used as a loading control. Graphic representations of mRNA decay rates are indicated on the right panels where mRNA levels from different time points (after ACT-D with or without SIN treatments) were expressed relative to time 0. Data are derived from two experiments for the amastigote data and four experiments for the promastigote data. The absolute mRNA half-life values (*t*~1/2~) are indicated. See [Table 1](#T1){ref-type="table"} for the entire complement of mRNA half-lives calculated in this study and their corresponding standard errors.

A U-rich **∼**100 bases region in the 3′UTR of the amastin mRNA contributes significantly to its stage-specific accumulation and its facilitated degradation in promastigotes
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Next, we assessed whether the amastin mRNA regulation could be attributed to a distinct element in its 1.8 kb long 3′UTR. We have previously shown that the last 770 bases region of the amastin 3′UTR, in-and-by itself, does not account for stage-specific accumulation of the amastin mRNA ([@B33]). Sequence scanning of the rest of the 3′UTR revealed that it contains a ∼100 bases long U-rich sequence (URE) ([Figure 2](#F2){ref-type="fig"}A). Given the role of similar elements in the degradation of unstable mRNAs in other eukaryotes including *T. brucei* and *T. cruzi* \[reviewed in ([@B11],[@B34])\], we deleted this region in a construct which is otherwise identical to the LUC-3′UTR plasmid. The stable transfectant of this plasmid (LUC-3′UTRΔURE) was analyzed in parallel with that of the LUC-3′UTR. Copy number differences were ruled out by Southern blot analysis and comparison of *NEO* mRNA levels (data not shown). As shown in [Figure 2](#F2){ref-type="fig"}B, the *LUC-3′UTRΔURE* mRNA steady-state levels are ∼2.2-fold higher than that of *LUC-3′UTR* in promastigotes whereas no significant difference could be observed in amastigotes, suggesting that the URE accounts significantly for the stage-specific accumulation of the amastin mRNA. Decay analysis showed that the difference in the steady-state levels between *LUC-3′UTR* and *LUC-3′UTRΔURE* mRNA levels observed in promastigotes is accompanied by an overall increase in mRNA half-life from ∼30 to \>60 min ([Figure 3](#F3){ref-type="fig"}A and B, [Table 1](#T1){ref-type="table"}). No significant changes could be detected in amastigotes ([Figure 3](#F3){ref-type="fig"}C, [Table 1](#T1){ref-type="table"}). A more detailed comparison revealed that differences in degradation kinetics are more apparent in the initial phase (the first 15--30 min) than the later phase ([Figure 3](#F3){ref-type="fig"}A and B). Luciferase activity levels generally followed the mRNA trends ([Figure 2](#F2){ref-type="fig"}C, data not shown) and the URE-mediated mRNA degradation is, therefore, unlikely to be to due to differential translatability of the mRNA. Taken together, these results suggested that a significant part of the amastin mRNA degradation in promastigotes is URE-mediated and that this probably occurs during the initiation phase of the degradation.

Differential degradation of the amastin mRNA in promastigotes seems to be initiated via deadenylation-independent mechanisms
----------------------------------------------------------------------------------------------------------------------------

mRNA degradation in eukaryotes is typically initiated and modulated via differential deadenylation \[reviewed in ([@B13])\]. Thus, we asked if the promastigote-specific degradation of the amastin mRNA is due to rapid deadenylation. The endogenous amastin or *LUC-3′UTR* mRNAs are relatively long (∼2.6 and ∼3.5 kb, respectively) and changes in mRNA sizes due to deadenylation in ordinary RNA blot analysis would be difficult to visualize. We, therefore, like in many other previous studies by others \[e.g. ([@B24])\], exploited the DNA--RNA hybrid-dependent ribonuclease activity of RNase H to cleave these RNAs at specific sites and generate shorter 3′-end fragments. This was achieved by incubating RNA samples from several time points after ACT-D ± SIN treatments with RNase H in the presence of anti-sense oligonucleotide targeted to a region of ∼300 bases from the end of the amastin 3′UTR ([Figure 4](#F4){ref-type="fig"}A). Oligo dT was added in some samples so that the poly(A) tail could be cleaved off and the resulting fragment served as a marker for a ∼100% deadenylated mRNA species. This analysis in promastigotes showed that the poly(A) tail of the *LUC-3′UTR* mRNA is still intact (relative to time 0) long after a significant part of the mRNA body has been degraded ([Figure 4](#F4){ref-type="fig"}B, left panel). In contrast, a significant deadenylation clearly precedes the degradation of the mRNA in amastigotes ([Figure 4](#F4){ref-type="fig"}B, right panel). Interestingly, the deadenylation pattern of the relatively more stable *LUC-3′UTRΔURE* mRNA was not different between promastigotes ([Figure 4](#F4){ref-type="fig"}B, middle panel) and amastigotes (data not shown) and it remarkably resembles that of *LUC-3′UTR* in amastigotes ([Figure 4](#F4){ref-type="fig"}B, right panel). Noteworthy, a minor population of the *LUC-3′UTR* mRNA in promastigotes appears to be deadenylated at later time points (the last lanes in [Figure 4](#F4){ref-type="fig"}B, left panel and 4C) and is probably coincident with the second and slower phase of the mRNA degradation ([Figure 3](#F3){ref-type="fig"}A and B). Figure 4.Determination of poly(A) tail status during reporter mRNA decay. (**A**) Schematic representation of the deadenylation assay. RNase-H digests DNA/RNA hybrid. In this case the DNA is an oligonucleotide (300R), which is reverse complementary to a region of ∼300 bases upstream of the poly(A) tail of the reporter mRNA. The presence of oligo dT in the reaction allows the trimming of the poly(A) tails (see later). The vertical darker arrows indicate the sequence to which the oligonucleotide was targeted into. The last 300 bases of the 3′UTR is underlined and is where the probe for the RNA blots was targeted. (**B**) Deadenylation of reporter mRNAs in promastigotes (Pro) and amastigotes (Ama). RNA samples were collected from different time points after treatment with ACT-D and subjected to RNase-H treatment. 3′ fragments were analysed by RNA blot. At time 0, RNA samples were also treated with RNase-H digestion in the presence of oligo dT (in addition to the specific oligonucleotide) to generate poly(A) minus 3′-end markers ('0 + dT' lanes). Hist 4A is used as a loading control. (**C**) As in (B) but RNA was derived from ACT-D and SIN treatment of *LUC-3′UTR* promastigotes. Data are representative of three experiments. (**D**) Quantitative representation of the decay rate of *LUC-3′UTR* polyadenylated 3′-end fragments in promastigotes (B, left panel) is compared to that of the full-length *LUC-3′UTR* mRNA in promastigotes (Figure 3A). The lateral bracket indicated in Figure 4B left panel shows the portion of the gel used for quantification of the largely poly(A)+ 3′-end fragments. Note that the full-length *LUC-3′UTR* mRNA used for this quantification was probed by the luciferase coding sequence, which is ∼1.8 kb upstream of the polyadenylation site while the 3′-end products of the RNase H were probed by the last 300 terminal sequence of the 3′-end.

We carried out a similar analysis for the endogenous amastin mRNA both in promastigotes and amastigotes. In order to detect the deadenylation pattern of the endogenous amastin mRNA in promastigotes (expression of the amastin mRNA is much higher in amastigotes compared to promastigotes), we had to increase the sensitivity of the assay and to expose the Northern blots much longer. This analysis shows that consistent with the reporter mRNA results described earlier ([Figure 4](#F4){ref-type="fig"}B, left panel), the amastin mRNA in promastigotes---in contrast to the same mRNA in amastigotes---is degraded without detectable deadenylation ([Figure 5](#F5){ref-type="fig"}A and C upper panel). We next wanted to assess the deadenylation profile of the amastin mRNA during differentiation. To induce differentiation *in vitro*, we subject amastigotes grown at 37°C and pH 5.8 to promastigote conditions (25°C and pH 7.0) of growth. Approximately 5 h following the switch from amastigote to promastigote conditions, a significant decrease in amastin mRNA levels could be observed ([Figure 5](#F5){ref-type="fig"}B). Interestingly, under these conditions, the deadenylation pattern of the endogenous amastin mRNA ([Figure 5](#F5){ref-type="fig"}C lower panel) was comparable to that seen using adapted promastigote cultures ([Figure 5](#F5){ref-type="fig"}A). Overall, these results suggest that the initial phase of the degradation of the amastin mRNA in promastigotes *per se* is likely to be deadenylation-independent and that the stage-specific regulation of the amastin mRNA is unlikely to be a function of differential deadenylation rate. Figure 5.Deadenylation analysis of the endogenous amastin mRNA. (**A**) RNase H-RNA blot deadenylation assay for assessing deadenylation of the endogenous amastin mRNA in promastigotes. RNA samples were collected at 0, 15 and 30 min (half-life of the endogenous mRNA in promastigotes, see Figure 1B) following transcriptional arrest with Actinomycin-D (ACT-D) (left panel) and treatment with ACT-D plus Sinefungin (SIN) to inhibit splicing (right panel) and subjected to RNase-H treatment as detailed in Figure 4 and under 'Materials and Methods' section. (**B**) Time-point analysis of the amastin mRNA during a switch from axenic amastigote (Ama) (pH 5.8, 37°C) to promastigote (Pro) (pH 7.0, 25°C) conditions. Blots were probed with the probe 300 fragment. (**C**) RNase H-RNA blot deadenylation assay. The 5 h post-switch was selected based on the data presented in (B), a time point where a detectable decrease in mRNA level was observed and yet not down to an extent below the detection limit of the deadenylation assay. RNA samples were run on 5% polyacrylamide gels. Other methodological details for the deadenylation analysis are as in Figure 4. The data are representative of two experiments.

Is decapping the rate-limiting step for the promastigote-specific degradation of the amastin mRNA?
--------------------------------------------------------------------------------------------------

Deadenylation-independent mechanisms of mRNA degradation are rare in eukaryotes and are mainly initiated via an endonuclease or deadenylation-independent decapping activities. A role for a decapping mechanism is usually demonstrated via genetic or RNA interference (RNAi) approaches. However, no clear homologue of a decapping enzyme could so far be identified in the genomes of trypanosomatids. We, therefore, resorted in this study into an indirect assessment of the decapping rate of the *LUC-3′UTR* mRNA versus the *LUC-3′UTRΔURE* mRNA in promastigotes. To do this, we took advantage of the commercially available 5′-phosphate-dependent riboexonuclease, Terminator, which has so far been used mainly to enrich mRNA preparation as the enzyme degrades all uncapped RNAs (e.g. decapped mRNAs, rRNAs, tRNAs) while capped mRNAs are protected. A recent study has made use of the enzyme to qualitatively access the cap status of a deadenylated intermediate of the *hsp70* mRNA ([@B53]). Here, we anticipated that relative mRNA decapping rates could quantitatively be inferred by comparison of Terminator treated versus untreated RNA samples derived from various time points after transcriptional arrest. For this assay, uncapped rRNAs that are cleaved by the enzyme served as positive controls (with 50--80% efficiency in our case). Histone 4A (*Hist4A*) mRNA is very stable within the time points used in the assay and therefore served as a negative control and indicated that the enzyme is highly specific ([Figure 6](#F6){ref-type="fig"}A). Tube-to-tube variations in the efficiency of the Terminator activity were corrected with the levels of 18S RNA after loading normalization with the *Hist4A* mRNA ([Figure 6](#F6){ref-type="fig"}A). Values from Terminator-treated samples were then divided by those from Terminator-untreated samples. The resulting numbers for each of the various time points after ACT-D treatment were expressed as a function of time 0. Such analysis indicated that there is no significant difference between the percentage of capped *LUC-3′UTR* and *LUC-3′UTRΔURE* mRNAs at various time points after transcriptional arrest (relative to time 0) ([Figure 6](#F6){ref-type="fig"}B). These results, within the limits of the assay employed, suggested that no detectable difference in decapping rate can account for the URE-mediated facilitated degradation of the amastin mRNA in promastigotes. Figure 6.Indirect measurement of decapping rates. (**A**) RNA samples were derived from LUC-3′UTR and LUC-3′UTRΔURE lines treated with actinomycin-D (ACT-D) for different time points. An equal volume of RNA was separated into two different tubes. One set of the tubes contained the reaction mix containing the Terminator enzyme (+ lanes) and the other contained the same mix but without the enzyme (-- lanes). Both Terminator -- and + reactions were incubated for 1--1.5 h according to manufacturer\'s instructions (Epicentre Biotechnologies). Data are representative of two experiments. Similar results were obtained in two other experiments involving ACT-D and SIN (data not shown). 18S RNA signals were used to control for tube-to-tube variation of Terminator degradation efficiency after normalization of loading with histone 4A (*Hist4A*) mRNA. (**B**) Graphic representation of the ratio of + Terminator signals to -- Terminator signals relative to time 0.

DISCUSSION
==========

In this study, we began a series of experiments aimed at dissecting the mechanisms of mRNA degradation responsible for the expression of stage-specific mRNAs in *Leishmania*. Specifically, we studied the degradation of the amastin mRNA, which was previously shown to be more abundant in amastigotes than in promastigotes ([@B51]). Further interest in undertaking this study stems from the observations that the amastin gene encodes a putative surface protein and is a member of multi-gene family with an expected role in the biology and/or pathobiology of the parasite ([@B49],[@B50]).

In common with a number of other previously studied mRNAs, the stage-specific amastin mRNA is regulated via sequences in its 3′UTR at the level of mRNA stability. Sequence analysis of its 3′UTR revealed the presence of a ∼100 bases long U-rich sequence (URE) and our reporter mRNA analysis showed that this element contributes significantly to the stage-specific accumulation and degradation of the amastin mRNA. A similar role of UREs was previously shown for *T. brucei* and *T. cruzi* mRNAs \[reviewed in ([@B11],[@B34])\], suggesting that this mechanism is probably conserved in trypanosomatids. Noteworthy, the designation of this element as a URE, and its reference relative to elements in other eukaryotes, is solely based on the relatively high (50%) U-content of the region. Also, the specific regulatory region within the element, if distinct at all, might not necessarily be as U-rich.

The URE does not seem to account for all of the stage-specific regulation of the amastin mRNA. If any, the rest of the amastin mRNA regulation might be explained by other elements in its 1.8 kb 3′UTR. The 3′UTR of the amastin mRNA contains a sequence related to the *Leishmania* specific SIDER1 retroelements ([@B31]). We have previously shown that the amastin SIDER1 alone does not alter reporter RNA levels ([@B33]). However, the possibility that it might have a context dependent function, perhaps in synergy with the URE, remains to be tested.

mRNA decay analysis of the amastin mRNA revealed a remarkable resemblance of degradation kinetics with that of unstable mRNAs in *T. brucei*. Unlike the degradation of the stable mRNAs, at least the initial phase of the degradation of unstable URE-containing mRNAs appears to be deadenylation-independent ([@B24],[@B29]). At least at first glance, an alternative interpretation of the deadenylation analysis we employed in this study can be associated with the possibility that deadenylated species of the endogenous amastin or *LUC-3′UTR* mRNAs in promastigotes might be degraded too fast to be detectable. Our data do not rule out the singular possibility that deadenylated amastin mRNA species might be degraded faster in promastigotes. However, whether the differential degradation of the amastin mRNA is mediated through and/or preceded by undetectable deadenylation is altogether a different question. Several indications seem to go against this possibility. First, there are no appreciable levels of deadenylated species at time 0 and at early time points following actinomycin D treatment. Secondly, deadenylated species are actually detectable in the later time points ([Figure 4](#F4){ref-type="fig"}B left panel and [Figure 4](#F4){ref-type="fig"}C). Thirdly, as mRNAs get deadenylated, there must be a proportional decrease of the poly(A) plus mRNAs. This would imply that the remaining polyadenylated portion of the 3′-end fragments should disappear faster relative to the full-length mRNA. However, our results did not indicate that this is the case ([Figures 3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}). In fact, the decay kinetics of the non-deadenylated 3′-end fragments was not distinguishable from those of the full-length, RNase-H-untreated mRNAs ([Figure 4](#F4){ref-type="fig"}D). Fourthly, we did not observe detectable differences when we compared degradation from the 5′- and 3′-ends in RNase H-RNA blots using an oligonucleotide that allowed cutting at ∼800 bases upstream of the 3′-end and subsequent detection with region-specific probes (see Supplementary Data in Figure S1). Indeed, RNAi-mediated depletion of a homologue of a yeast deadenylase in *T. brucei* has minimal effects on the degradation kinetics of unstable mRNAs (including URE-mRNAs) while that of moderately and highly stable mRNAs is clearly altered (personal communication by Dr Clayton, ZMBH, Germany). These observations collectively compelled us to conclude that the URE-mediated promastigote-specific degradation of the amastin mRNA is deadenylation-independent. It is, therefore, tempting to suggest that the likely possibility that deadenylated species might be degraded faster in promastigotes can instead be viewed as further evidence to our conclusion; namely that URE amastin mRNAs are degraded faster in promastigotes regardless of whether they contain poly(A) or not (i.e. degradation is independent of deadenylation status).

Significant levels of deadenylated species are detectable at steady-state in both stages of the parasite. This is a surprising observation because deadenylated mRNAs are considered to be unstable. Interestingly, a recent global analysis of poly(A) length of mammalian mRNAs has revealed a surprisingly high proportion of the mRNAs (∼25%) having oligoadenylated species with only \<30 length of poly(A) ([@B54]). Even a more surprising finding of the study by Meijer *et al.* is that some stable mRNAs fall among these mRNAs. For example, 25% of the beta-actin mRNA, an mRNA known to be very stable, contained a short poly(A) tail. These observations collectively challenge the current notion that deadenylated mRNA species are unstable. A related observation in this study is that a higher proportion of deadenylated and oligoadenylated species are detected for stable mRNAs (the amastin or *LUC-3′UTR* mRNAs in amastigotes and the *LUC-3′UTRΔURE* mRNA in both stages) than unstable mRNAs (the amastin and *LUC-3′UTR* mRNAs in promastigotes). This can be because the deadenylated species are degraded faster in promastigotes. Alternatively, this can be viewed as an indication for the possibility that the URE-mediated regulation of the amastin mRNA is not only deadenylation-independent but also polyadenylation-dependent. In other words, the poly(A) tail might have a destabilizing role rather than a stabilizing one. In bacteria, poly(A) tail serves as a 'holding toe' for 3′-exonucleases thereby facilitating degradation ([@B55]). However, this is not the case for almost all functional eukaryotic mRNAs studied so far. The few cases where poly(A) tail has a destabilizing function in eukaryotes fall within the realms of nuclear RNA degradation of certain pre-mRNAs and/or aberrant mRNAs as part of quality-control mechanisms ([@B56; @B57; @B58]).

Mechanisms of deadenylation-independent mRNA degradation, albeit rare, include deadenylation-independent decapping mechanisms such as the one associated with at least one pathway of the non-sense-mediated decay ([@B59],[@B60]). Unfortunately, no clear homologue to any of the decapping enzymes from other eukaryotes has so far been identified in the genomes of trypanosomatids even though *in vitro* decapping activity was biochemically detected in a related species ([@B23]). In this study, we attempted to indirectly compare decapping rates by taking advantage of a 5′-phosphate-dependent enzyme, Terminator. This analysis did not show a significant difference between *LUC-3′UTR* and *LUC-3′UTRΔURE* mRNAs in promastigotes suggesting the differential mRNA degradation is unlikely to be a function of an altered decapping rate. We, therefore, favor the scenario that an endonuclease-mediated cleavage might be the rate-limiting step, a well-studied example of which can be found in the degradation of the mammalian alpha-globin mRNA \[reviewed in ([@B61])\]. Alternatively, a novel pathway might be awaiting a discovery.

Our current model of the amastin mRNA degradation based on this study, and in analogy with the situation in *T. brucei*, is that two mechanisms are likely to be involved: one that appears to be deadenylation- and decapping-independent, URE-mediated rapid degradation that is developmentally regulated, and the other is constitutive, which is likely to be slower and deadenylation-dependent ([Figure 7](#F7){ref-type="fig"}). This study is the first not only in reporting a URE-mediated degradation in *Leishmania* but also in attempting to draw the mechanistic basis of differential mRNA degradation in this parasite. The extent to which URE-mediated degradation differs from mammalian ARE-mediated mRNA instability and whether there are species-specific aspects of this mechanism among trypanosomatids remain to be determined. Figure 7.A proposed model for the stage-specific mRNA degradation of the amastin mRNA. A significant part of the promastigote-specific facilitated degradation of the amastin mRNA (and the *LUC-3′UTR* mRNA) is URE-dependent, is mostly deadenylation-independent and probably decapping-independent (**A**). An additional unknown mechanism that is URE-independent (**B**) might be involved as well because deletion of the URE did not account for all of the stage-specific mRNA regulation at the steady-state levels as indicated in Figure 2. A constitutive deadenylation-dependent pathway (**C**) is responsible for the decay of more stable mRNAs *(LUC-3′UTRΔURE* in both developmental forms, and the amastin and *LUC-3′UTR* mRNAs in amastigotes). A minor sub-population of the amastin and *LUC-3′UTR* mRNAs in promastigotes is probably degraded via a deadenylation-dependent constitutive pathway.
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[^1]: Decay rates for the endogenous amastin, *LUC-3′UTR* and *LUC-3′UTRΔURE* mRNAs in promastigotes (Pro) and axenic amastigotes (Ama) were determined after transcriptional inhibition using Actinomycin D (ACT-D) with or without splicing arrest using Sinefungin (SIN).

[^2]: ^a^Despite the variation of the absolute half-life values which are directly reflected in this Table, *LUC-3′UTRΔURE* mRNA was consistently more stable than *LUC-3′UTR* mRNA in promastigotes in each of the four independent experiments we carried out whereas no significant differences were observed between these two RNAs in amastigotes. Numerically, this parameter is reflected by the average of the relative differences (the half-life of *LUC-3′UTRΔURE* mRNA minus that of the *LUC-3′UTR* mRNA), which is 34 min ± an SD of 8 min.
